R&D to Revenue
448.97%
Quarterly · Period ending:
MRNA R&D to Revenue
Latest reported448.97%period ending
Latest reported448.97%period ending
MRNA Quarterly R&D/Revenue (278.55% → 448.97%)
Latest values, visible window
High-resolution chart · PNG
MRNA r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 448.9655% | |
| 166.838% | |
| 114.3068% | |
| 78.8386% | |
| 492.9577% | |
| 800% | |
| 117.364% | |
| 61.2938% | |
| 552.4887% | |
| 614.9701% | |
| 49.9822% | |
| 63.3534% | |
| 333.7209% | |
| 61.5343% | |
| 23.5191% | |
| 25.4658% | |
| 15.5497% | |
| 9.3266% | |
| 9.3251% | |
| 10.789% | |
| 9.9881% | |
| 23.0063% | |
| 132.9596% | |
| 218.1534% | |
| 228.8677% | |
| 1,372.4759% | |
| 836.1651% | |
| 702.3055% | |
| 982.1601% | |
| 814.8206% | |
| 424.6887% | |
| 261.1538% | |
| 362.133% | |
| 310.355% | |
| 128.2066% | |
| 220.4059% | |
| 278.5508% | |
| 278.5508% |